Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients' Unmet Needs and Exploring Future Applications.

MLA

Ingrasciotta, Ylenia, et al. “Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications.” Journal of Clinical Medicine, vol. 13, no. 7, Apr. 2024, p. 2113. EBSCOhost, https://doi.org/10.3390/jcm13072113.

APA

Ingrasciotta, Y., Vitturi, G., & Trifirò, G. (2024). Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications. Journal of Clinical Medicine, 13(7), 2113. https://doi.org/10.3390/jcm13072113

Chicago

Ingrasciotta, Ylenia, Giacomo Vitturi, and Gianluca Trifirò. 2024. “Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications.” Journal of Clinical Medicine 13 (7): 2113. doi:10.3390/jcm13072113.